BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4992570)

  • 1. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
    Balodimos MC; Marble A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
    Sherwood G; Bressler R
    Curr Ther Res Clin Exp; 1968 Aug; 10(8):399-405. PubMed ID: 4970053
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
    Kanzler G; Trenkner G; Rausch-Stroomann JB
    Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of tolinase (tolazamide) in diabetes mellitus].
    Genes SG; Grinchenko TS; Lobanovskaia LI
    Vrach Delo; 1969 Apr; 4():40-4. PubMed ID: 5373588
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of tolazamide in the treatment of diabetes mellitus.
    Beidleman B; Prevatt AL; Palmer RC
    J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
    [No Abstract]   [Full Text] [Related]  

  • 9. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tolazamide in the control of diabetes mellitus].
    Ramos JV
    Prensa Med Mex; 1969; 34(1):66-7. PubMed ID: 5787505
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
    Tewari SN; Fletcher R
    Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose and insulin after diet and tolazamide treatment.
    Sheldon J
    Br Med J; 1970 Oct; 4(5729):246. PubMed ID: 5472796
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolanase - a sulphonylurea antidiabetic agent.
    Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
    [No Abstract]   [Full Text] [Related]  

  • 16. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of diabetes mellitus with tolazamide].
    Nava M; Mendoza M
    Prensa Med Mex; 1967; 32(1):56-8. PubMed ID: 5633826
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
    Domingo Gutiérrez AJ
    Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.